Pharmaceutical companies & Afghanistan

(Reading time: 1 minute)

Over 90 billion dollars a year. That's what pharmaceutical companies bill by selling opiate-based drugs. Much of this opium comes from Afghanistan, whose production has increased by 5.000.000% since the war began 18 years ago. The only people who benefit from that conflict are not the Afghans, who are nearly as bad as they were under the Taliban, but they are pharmaceutical companies, arms manufacturers, mercenary companies, mafias and Islamic extremists, including Al Qaeda and ISIS.